3 Comments

    1. SS:

      Stock prices for mpox vaccine maker Bavarian Nordic surged after the World Health Organization (WHO) on Wednesday declared mpox a global public health emergency.

      The company’s share prices jumped 17% in early trading in Copenhagen today, Forbes reported, after climbing 12% yesterday when the WHO made its announcement. In the U.S., shares were up 33% this morning.

      The DRC, where the outbreak is concentrated and most severe, has approved two vaccines — Japan’s LC16 and Bavarian Nordic’s Jynneos, which is also marketed as Imvamune and Imvanex.

      Coming to a
      ​​theater near you
      September 2024
      Get Tickets

      Bavarian Nordic is one of the few companies in the world with an already-approved mpox vaccine that is also available in large quantities. Other contenders, such as Emergent BioSolutions’ ACAM2000 have been available under special investigational protocols. Others, like Tonix Pharmaceuticals, have experimental shots that are in earlier stages of development.

      LC16 is a smallpox vaccine licensed in 1980 in Japan and approved in July 2022 for mpox. It isn’t commercially available, but there are large supplies in Japan’s national stockpile, the Center for Infectious Disease Research and Policy reported. Like Jynneos, it is a third-generation mpox vaccine that uses attenuated virus strains.

    2. whats_good_is_bad on

      Worth noting that this is an old school vaccine and does not contain the MRNA gene editing tech of the recent COVID vax. Dr.John Campbell has a good video on this just up in the past few days.

    3. When they started the MPox psyop the first time a few years back, I read on this sub that Bill Gates had invested in SIGA pharmaceuticals as they were doing a vaccine. So I bought in, and made a shit load of money. I firmly believe these psyops are just stock market schemes if you’re in the loop.

    Leave A Reply